Layton DM - Search Results

1

Quantification of Ggamma- and Agamma-globins by electrospray ionisation mass spectrometry.

Ofori-Acquah SF, Green BN, Wild BJ, Lalloz MR, Layton DM. Ofori-Acquah SF, et al. Among authors: layton dm. Int J Mol Med. 1998 Oct;2(4):451-3. doi: 10.3892/ijmm.2.4.451. Int J Mol Med. 1998. PMID: 9857233

2

Localisation of cis regulatory elements at the beta-globin locus: analysis of hybrid haplotype chromosomes.

Ofori-Acquah SF, Lalloz MR, Layton DM. Ofori-Acquah SF, et al. Among authors: layton dm. Biochem Biophys Res Commun. 1999 Jan 8;254(1):181-7. doi: 10.1006/bbrc.1998.9901. Biochem Biophys Res Commun. 1999. PMID: 9920754

3

Rapid identification of hemoglobin variants by electrospray ionization mass spectrometry.

Wild BJ, Green BN, Cooper EK, Lalloz MR, Erten S, Stephens AD, Layton DM. Wild BJ, et al. Among authors: layton dm. Blood Cells Mol Dis. 2001 May-Jun;27(3):691-704. doi: 10.1006/bcmd.2001.0430. Blood Cells Mol Dis. 2001. PMID: 11482884

4

Mass spectral analysis of asymmetric hemoglobin hybrids: demonstration of Hb FS (alpha2gammabetaS) in sickle cell disease.

Ofori-Acquah SF, Green BN, Davies SC, Nicolaides KH, Serjeant GR, Layton DM. Ofori-Acquah SF, et al. Among authors: layton dm. Anal Biochem. 2001 Nov 1;298(1):76-82. doi: 10.1006/abio.2001.5358. Anal Biochem. 2001. PMID: 11673898 Clinical Trial.

5

Nucleotide variation regulates the level of enhancement by hypersensitive site 2 of the beta-globin locus control region.

Ofori-Acquah SF, Lalloz MR, Layton DM. Ofori-Acquah SF, et al. Among authors: layton dm. Blood Cells Mol Dis. 2001 Sep-Oct;27(5):803-11. doi: 10.1006/bcmd.2001.0449. Blood Cells Mol Dis. 2001. PMID: 11783943

6

Dominant influence of gamma-globin promoter polymorphisms on fetal haemoglobin expression in sickle cell disease.

Ofori-Acquah SF, Lalloz MR, Serjeant G, Layton DM. Ofori-Acquah SF, et al. Among authors: layton dm. Cell Mol Biol (Noisy-le-grand). 2004 Feb;50(1):35-42. Cell Mol Biol (Noisy-le-grand). 2004. PMID: 15040425

7

Prenatal diagnosis of triosephosphate isomerase deficiency.

Arya R, Lalloz MR, Nicolaides KH, Bellingham AJ, Layton DM. Arya R, et al. Among authors: layton dm. Blood. 1996 Jun 1;87(11):4507-9. Blood. 1996. PMID: 8639817 Free article.

8

Evidence for founder effect of the Glu104Asp substitution and identification of new mutations in triosephosphate isomerase deficiency.

Arya R, Lalloz MR, Bellingham AJ, Layton DM. Arya R, et al. Among authors: layton dm. Hum Mutat. 1997;10(4):290-4. doi: 10.1002/(SICI)1098-1004(1997)10:4<290::AID-HUMU4>3.0.CO;2-L. Hum Mutat. 1997. PMID: 9338582

9

Ancestral origin of variation in the triosephosphate isomerase gene promoter.

Humphries A, Ationu A, Lalloz MR, Layton DM. Humphries A, et al. Among authors: layton dm. Hum Genet. 1999 Jun;104(6):486-91. doi: 10.1007/s004390050992. Hum Genet. 1999. PMID: 10453737

10

Reversal of metabolic block in glycolysis by enzyme replacement in triosephosphate isomerase-deficient cells.

Ationu A, Humphries A, Lalloz MR, Arya R, Wild B, Warrilow J, Morgan J, Bellingham AJ, Layton DM. Ationu A, et al. Among authors: layton dm. Blood. 1999 Nov 1;94(9):3193-8. Blood. 1999. PMID: 10556207 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

116 results

Search Page

Filters